期刊文献+

皮下注射奥曲肽预防胰十二指肠切除术后腹内并发症的效果分析

Subcutaneous injection of octreotide in the prevention of intra - abdominal complications following pancreatoduodenectomy
暂未订购
导出
摘要 目的分析皮下注射奥曲肽对预防胰十二指肠切除术后腹内并发症的预防效果。方法回顾性分析2003年1月至2008年12月间施行的68例胰十二指肠切除术患者的临床资料,其中对照组31例,奥曲肽治疗组(奥曲肽组)37例。从手术后当日至术后5d奥曲肽组每天3次皮下注射奥曲肽,每次0.1mg,观察胰漏、腹腔并发症发生率。结果奥曲肽组腹内并发症发生率显著低于对照组,差异有统计学意义(P〈0.05);胰漏发生率低于对照组,但差异无统计学意义(P〉0.05)。结论经皮下注射奥曲肽能显著降低胰十二指肠切除术后腹内并发症发生率。 Objective To examine the effect of subcutaneous injection of octreotide in the prevention of intra - abdominal complications after pancreatoduodenectomy. Methods The clinical data of 68 cases of pancreatoduodenectomy performed from January 2003 to December 2008 were retrospectively analyzed. Thirty - one cases in the control group were not injected with octreotide. In the octreotide group, 37 patients were subcutaneously injected with octreotide 0.1 mg three times daily from post - operative day 0 to day 5. The intra - abdominal complications and pancreatic fistulas were observed. Results The in- cidence of intra - abdominal complications and pancreatic fistulas were significantly lower in the octreotide group than those in the control group with differences being significant (P 〈 0.05 for each). Conclusion Subcutaneous injection of octreotide can significantly reduce the incidence of intra - abdominal complications after pancreatoduodenectomy
作者 李昌 任泽强
出处 《临床外科杂志》 2010年第6期384-385,共2页 Journal of Clinical Surgery
关键词 胰十二指肠切除术 奥曲肽 术后并发症 胰漏 pancreatoduodenectomy octreotide postoperative complications pancreatic fistula
  • 相关文献

参考文献4

  • 1周亚魁,洪淑芳.奥曲肽在普外科的临床应用及其进展[J].中华肝胆外科杂志,2000,6(4):306-309. 被引量:7
  • 2Montorsi M,Zago M,Mosca F,et al.Efficacy of octreotide in the prevention of complication fistula after elective pancreatic resections:a prospective,controlled randomized trial[J].Surgery,1995,117(6):26-31.
  • 3Yeo CJ,Cameron JL,Sohn TA,et al.Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial[J].Ann Surg,2000,232(3):419-429.
  • 4Suc B,Msika S,Piccinini M,et al.Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection[J].Arch Surg,2004,139(3):288-294.

二级参考文献3

  • 1Dr. Vincenzo Francesco MD,Giampaolo Angelini MD,Paolo Bovo MD,Maria Beatrice Casarini MD,Marco Filippini MD,Bruna Vaona MD,Luca Frulloni MD,Laura Rigo MD,Maria Paola Brunori MD,Giorgio Cavallini MD. Effect of octreotide on sphincter of oddi motility in patients with acute recurrent pancreatitis[J] 1996,Digestive Diseases and Sciences(12):2392~2396
  • 2Haim Paran M.D.,David Neufeld M.D.,Ofer Kaplan M.D.,Joseph Klausner M.D.,Uri Freund M.D.. Octreotide for treatment of postoperative alimentary tract fistulas[J] 1995,World Journal of Surgery(3):430~433
  • 3Kenneth F. Binmoeller MD,Remy Dumas MD,Alan G. Harris MD,Prof. J. P. Delmont MD. Effect of somatostatin analog octreotide on human sphincter of Oddi[J] 1992,Digestive Diseases and Sciences(5):773~777

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部